Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Charles River Laboratories International, Inc. CRL
$190.83
-$4.8 (-2.52%)
На 18:00, 12 мая 2023
+93.50%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
9989684197.00000000
-
week52high
262.00
-
week52low
181.22
-
Revenue
3976060000
-
P/E TTM
20
-
Beta
1.34394400
-
EPS
9.43000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 12:30
Описание компании
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Outperform | 25 авг 2022 г. | |
| Wells Fargo | Overweight | Overweight | 16 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Overweight | 04 авг 2022 г. |
| Deutsche Bank | Buy | Buy | 14 июл 2022 г. |
| Guggenheim | Neutral | 24 мая 2022 г. | |
| Jefferies | Buy | Hold | 30 сент 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 03 ноя 2022 г. |
| JP Morgan | Overweight | Overweight | 03 ноя 2022 г. |
| Credit Suisse | Outperform | Outperform | 03 ноя 2022 г. |
| Jefferies | Hold | Buy | 12 янв 2023 г. |
| Baird | Outperform | Outperform | 11 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Creamer Victoria L | D | 15496 | 2692 | 31 янв 2023 г. |
| FOSTER JAMES C | D | 232922 | 21453 | 27 янв 2023 г. |
| FOSTER JAMES C | A | 254375 | 49725 | 27 янв 2023 г. |
| Parisotto Shannon M | D | 6010 | 1309 | 27 янв 2023 г. |
| Parisotto Shannon M | A | 7319 | 4820 | 27 янв 2023 г. |
| Creamer Victoria L | A | 18188 | 7229 | 27 янв 2023 г. |
| Barbo William D | D | 8763 | 2897 | 27 янв 2023 г. |
| Barbo William D | A | 11660 | 7857 | 27 янв 2023 г. |
| LaPlume Joseph W | D | 25647 | 3261 | 27 янв 2023 г. |
| LaPlume Joseph W | A | 28908 | 8676 | 27 янв 2023 г. |
Новостная лента
Charles River: Strong Earnings Manifest Life Science Megatrends
Seeking Alpha
11 мая 2023 г. в 23:09
In the past year, Charles River (-13.59%) has trailed both the S&P 500 (+4.83%) in addition to the healthcare index, IXHC (+21.81%). This reflects a -44.57% YoY free cash flow decline owing to material reductions in net income from 2021-22.
Charles River (CRL) Q1 Earnings Top Estimates, View Narrowed
Zacks Investment Research
11 мая 2023 г. в 12:57
Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.
Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
11 мая 2023 г. в 09:56
Charles River Laboratories (CRL) came out with quarterly earnings of $2.78 per share, beating the Zacks Consensus Estimate of $2.59 per share. This compares to earnings of $2.75 per share a year ago.
Charles River (CRL) to Report Q1 Earnings: What's in Store?
Zacks Investment Research
01 мая 2023 г. в 12:57
Continued global demand for research models and associated services are likely to have driven Charles River's (CRL) Q1 revenues.
3 Healthcare Stocks With Huge Growth Potential
InvestorPlace
24 апр 2023 г. в 18:21
It's been a rocky market for growth stocks over the past 18 months. We've seen a flurry of layoffs and spending cutbacks from leading tech companies.